Vaxcyte (PCVX) shares outstanding

Shares outstanding · fiscal 2025
136.09M

Vaxcyte (PCVX) had 136.09M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 11.6% higher than the 122.00M of fiscal 2024. Figures as of 18 Nov 2026, 11:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
136.09M
Change on fiscal 2024
+11.6%
Growth, 5 years
+35.7% a year
Highest on record
136.09Mfiscal 2025
Lowest on record
29.55Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Vaxcyte shares outstanding, in more detail

The market data feed counts 158.30M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 35.7% a year. Across the 6 fiscal years on record (2020–2025), the highest was 136.09M in fiscal 2025 and the lowest 29.55M in fiscal 2020.

History · 6 fiscal years

Shares outstanding by fiscal year

Vaxcyte shares outstanding, year by year

Vaxcyte (PCVX) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025136.09M 11.6% up
2024122.00M 25.6% up
202397.16M 49.8% up
202264.88M 25.0% up
202151.92M 75.7% up
202029.55M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Vaxcyte and comparable companies
CompanyShares outstandingFiscal year
Avantor AVTR680.60M2025
Ensign Group ENSG58.87M2025
Vaxcyte PCVX136.09M2025
Bio-Rad Laboratories BIO27.28M2025
Molina Healthcare MOH52.90M2025
Spyre Therapeutics SYRE64.06M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PCVX

Vaxcyte, figure by figure

Vaxcyte (PCVX) overview: price, valuation and scorecardAll health care companies by market value

Vaxcyte shares outstanding: questions and answers

How many shares does Vaxcyte have?

Vaxcyte (PCVX) had 136.09M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 11.6% higher than the 122.00M of fiscal 2024. The market data feed counts 158.30M shares outstanding today.

What is the growth rate of Vaxcyte's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 35.7% a year.

What are the highest and lowest diluted share count figures on record for Vaxcyte?

Across the 6 fiscal years on record (2020–2025), the highest was 136.09M in fiscal 2025 and the lowest 29.55M in fiscal 2020.

How is Vaxcyte's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Vaxcyte it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vaxcyte (PCVX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/PCVX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.